Ngā hua rapu - Richard T. Eastman

Whakamahine hua
  1. 1
    Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria

    Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria mā Richard T. Eastman, David A. Fidock

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Drug‐resistant malaria: Molecular mechanisms and implications for public health

    Drug‐resistant malaria: Molecular mechanisms and implications for public health mā Ines Petersen, Richard T. Eastman, Michael Lanzer

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Recent highlights in antimalarial drug resistance and chemotherapy research

    Recent highlights in antimalarial drug resistance and chemotherapy research mā David A. Fidock, Richard T. Eastman, Stephen A. Ward, Steven R. Meshnick

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Piperaquine Resistance Is Associated with a Copy Number Variation on Chromosome 5 in Drug-Pressured <i>Plasmodium falciparum</i> Parasites

    Piperaquine Resistance Is Associated with a Copy Number Variation on Chromosome 5 in Drug-Pressured <i>Plasmodium falciparum</i> Parasites mā Richard T. Eastman, Neekesh V. Dharia, Elizabeth A. Winzeler, David A. Fidock

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Thematic review series: Lipid Posttranslational Modifications. Fighting parasitic disease by blocking protein farnesylation

    Thematic review series: Lipid Posttranslational Modifications. Fighting parasitic disease by blocking protein farnesylation mā Richard T. Eastman, Frederick S. Buckner, Kohei Yokoyama, Michael H. Gelb, Wesley C. Van Voorhis

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    <i>Trypanosoma cruzi</i>Inactivation in Human Platelet Concentrates and Plasma by a Psoralen (Amotosalen HCl) and Long-Wavelength UV

    <i>Trypanosoma cruzi</i>Inactivation in Human Platelet Concentrates and Plasma by a Psoralen (Amotosalen HCl) and Long-Wavelength UV mā Wesley C. Van Voorhis, Lynn K. Barrett, Richard T. Eastman, Ryan Alfonso, Kent Dupuis

    I whakaputaina 2003
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19

    Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19 mā Richard T. Eastman, Jacob S. Roth, Kyle R. Brimacombe, Anton Simeonov, Min Shen, Samarjit Patnaik, Matthew D. Hall

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Screening the Pathogen Box for Molecules Active against Plasmodium Sexual Stages Using a New Nanoluciferase-Based Transgenic Line of P. berghei Identifies Transmission-Blocking Compounds

    Screening the Pathogen Box for Molecules Active against Plasmodium Sexual Stages Using a New Nanoluciferase-Based Transgenic Line of P. berghei Identifies Transmission-Blocking Com... mā Juliana Calit, Irina Dobrescu, Xiomara A. Gaitán, Miriam H. Borges, Marisé Solórzano Ramos, Richard T. Eastman, Daniel Y. Bargieri

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Genome‐wide profiling of chromosome interactions in <i><scp>P</scp>lasmodium falciparum</i> characterizes nuclear architecture and reconfigurations associated with antigenic variation

    Genome‐wide profiling of chromosome interactions in <i><scp>P</scp>lasmodium falciparum</i> characterizes nuclear architecture and reconfigurations associated with antigenic variat... mā Jacob E. Lemieux, Sue Kyes, Thomas D. Otto, Avi Feller, Richard T. Eastman, Robert Pinches, Matthew Berriman, Xin‐zhuan Su, Chris Newbold

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Synergistic and Antagonistic Drug Combinations against SARS-CoV-2

    Synergistic and Antagonistic Drug Combinations against SARS-CoV-2 mā Tesia Bobrowski, Lu Chen, Richard T. Eastman, Zina Itkin, Paul Shinn, Catherine Z. Chen, Hui Guo, Wei Zheng, Sam Michael, Anton Simeonov, Matthew D. Hall, Alexey Zakharov, Eugene Muratov

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Quantitative assessment of <i>Plasmodium falciparum</i> sexual development reveals potent transmission-blocking activity by methylene blue

    Quantitative assessment of <i>Plasmodium falciparum</i> sexual development reveals potent transmission-blocking activity by methylene blue mā Sophie Adjalley, Geoffrey L. Johnston, Tao Li, Richard T. Eastman, Eric H. Ekland, Abraham G. Eappen, Adam Richman, B. Kim Lee Sim, Lee M, Stephen L. Hoffman, David A. Fidock

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Novel Transmission-Blocking Antimalarials Identified by High-Throughput Screening of Plasmodium berghei Ookluc

    Novel Transmission-Blocking Antimalarials Identified by High-Throughput Screening of Plasmodium berghei Ookluc mā Juliana Calit, Jéssica E. Araújo, Bingbing Deng, Kazutoyo Miura, Xiomara A. Gaitán, Maísa da Silva Araújo, Jansen Fernandes Medeiros, Carole A. Long, Anton Simeonov, Richard T. Eastman, Daniel Y. Bargieri

    I whakaputaina 2023
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Resistance to a Protein Farnesyltransferase Inhibitor in Plasmodium falciparum

    Resistance to a Protein Farnesyltransferase Inhibitor in Plasmodium falciparum mā Richard T. Eastman, John White, Oliver Hucke, Kevin D. Bauer, Kohei Yokoyama, Laxman Nallan, Debopam Chakrabarti, Christophe L. M. J. Verlinde, Michael H. Gelb, Pradipsinh K. Rathod, Wesley C. Van Voorhis

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Supergenomic Network Compression and the Discovery of EXP1 as a Glutathione Transferase Inhibited by Artesunate

    Supergenomic Network Compression and the Discovery of EXP1 as a Glutathione Transferase Inhibited by Artesunate mā Andreas Martin Lisewski, Joel Patrick Quiros, Caroline L. Ng, Anbu Karani Adikesavan, Kazutoyo Miura, Nagireddy Putluri, Richard T. Eastman, Daniel Scanfeld, Sam Regenbogen, Lindsey M. Altenhofen, Manuel Llinás, Arun Sreekumar, Carole A. Long, David A. Fidock, Olivier Lichtarge

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    A single nucleotide polymorphism in the Plasmodium falciparum atg18 gene associates with artemisinin resistance and confers enhanced parasite survival under nutrient deprivation

    A single nucleotide polymorphism in the Plasmodium falciparum atg18 gene associates with artemisinin resistance and confers enhanced parasite survival under nutrient deprivation mā Kimberly F. Breglio, Roberto Amato, Richard T. Eastman, Pharath Lim, Juliana M. Sá, Rajarshi Guha, Sundar Ganesan, David W. Dorward, Carleen Klumpp‐Thomas, Crystal McKnight, Rick M. Fairhurst, David J. Roberts, Craig J. Thomas, Anna Katharina Simon

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors

    Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors mā Rachel P. M. Abrams, Adam Yasgar, T Teramoto, Myoung‐Hwa Lee, Dorjbal Dorjsuren, Richard T. Eastman, Nasir Malik, Alexey Zakharov, Wenxue Li, Muzna Bachani, Kyle R. Brimacombe, Joseph P. Steiner, Matthew D. Hall, Anuradha Balasubramanian, Ajit Jadhav, Radhakrishnan Padmanabhan, Anton Simeonov, Avindra Nath

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2

    Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2 mā Catherine Z. Chen, Paul Shinn, Zina Itkin, Richard T. Eastman, Robert Bostwick, Lynn Rasmussen, Ruili Huang, Min Shen, Xin Hu, Kelli M. Wilson, Brianna M. Brooks, Hui Guo, Tongan Zhao, Carleen Klump-Thomas, Anton Simeonov, Sam Michael, Donald C. Lo, Matthew D. Hall, Wei Zheng

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations

    High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations mā Bryan T. Mott, Richard T. Eastman, Rajarshi Guha, Katy S. Sherlach, Amila Siriwardana, Paul Shinn, Crystal McKnight, Sam Michael, Norinne Lacerda‐Queiroz, Paresma Patel, Pwint Khine, Hongmao Sun, Monica Kasbekar, Nima Aghdam, Shaun D. Fontaine, Dongbo Liu, Tim Mierzwa, Lesley Mathews-Griner, Marc Ferrer, Adam R. Renslo, James Inglese, Jing Yuan, Paul D. Roepe, Xin‐zhuan Su, Craig J. Thomas

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    A Specific Inhibitor of PfCDPK4 Blocks Malaria Transmission: Chemical-genetic Validation

    A Specific Inhibitor of PfCDPK4 Blocks Malaria Transmission: Chemical-genetic Validation mā Kayode K. Ojo, Richard T. Eastman, Ramasubbarao Vidadala, Zhongsheng Zhang, Kasey Rivas, Ryan Choi, Justin D. Lutz, Molly C. Reid, Anna M. W. Fox, Matthew A. Hulverson, Mark Kennedy, Nina Isoherranen, Laura M. Kim, Kenneth M. Comess, Dale J. Kempf, Christophe L. M. J. Verlinde, Xin‐zhuan Su, Stefan H. I. Kappe, Dustin J. Maly, Erkang Fan, Wesley C. Van Voorhis

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    An OpenData portal to share COVID-19 drug repurposing data in real time

    An OpenData portal to share COVID-19 drug repurposing data in real time mā Kyle R. Brimacombe, Tongan Zhao, Richard T. Eastman, Xin Hu, Ke Wang, Mark Backus, Bolormaa Baljinnyam, Catherine Z. Chen, Lu Chen, Tara Eicher, Marc Ferrer, Ying Fu, Kirill Gorshkov, Hui Guo, Quinlin Hanson, Zina Itkin, Stephen C. Kales, Carleen Klumpp‐Thomas, Emily M. Lee, Sam Michael, Tim Mierzwa, Andrew Patt, Manisha Pradhan, Alex Renn, Paul Shinn, Jonathan H. Shrimp, Amit Viraktamath, Kelli M. Wilson, Miao Xu, Alexey Zakharov, Wei Zhu, Wei Zheng, Anton Simeonov, Ewy A. Mathé, Donald C. Lo, Matthew D. Hall, Min Shen

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Pré-impressão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: